Zurich Cantonal Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,673
| Closed | -$1.16M | – | 2976 |
|
|
2022
Q3 | $1.16M | Buy |
7,673
+352
| +5% | +$53.2K | 0.01% | 809 |
|
|
2022
Q2 | $1.07M | Sell |
7,321
-584
| -7% | -$85.1K | 0.01% | 840 |
|
|
2022
Q1 | $937K | Sell |
7,905
-1,070
| -12% | -$127K | ﹤0.01% | 971 |
|
|
2021
Q4 | $1.24M | Buy |
8,975
+3,562
| +66% | +$491K | 0.01% | 913 |
|
|
2021
Q3 | $752K | Hold |
5,413
| – | – | ﹤0.01% | 1047 |
|
|
2021
Q2 | $525K | Sell |
5,413
-361
| -6% | -$35K | ﹤0.01% | 1207 |
|
|
2021
Q1 | $395K | Sell |
5,774
-1,008
| -15% | -$69K | ﹤0.01% | 1374 |
|
|
2020
Q4 | $581K | Buy |
6,782
+1,385
| +26% | +$119K | ﹤0.01% | 1200 |
|
|
2020
Q3 | $351K | Hold |
5,397
| – | – | ﹤0.01% | 1257 |
|
|
2020
Q2 | $395K | Buy |
5,397
+1,992
| +59% | +$146K | ﹤0.01% | 1128 |
|
|
2020
Q1 | $116K | Hold |
3,405
| – | – | ﹤0.01% | 1526 |
|
|
2019
Q4 | $185K | Buy |
3,405
+787
| +30% | +$42.8K | ﹤0.01% | 1385 |
|
|
2019
Q3 | $109K | Buy |
2,618
+362
| +16% | +$15.1K | ﹤0.01% | 1576 |
|
|
2019
Q2 | $99K | Buy |
2,256
+1,097
| +95% | +$48.1K | ﹤0.01% | 1634 |
|
|
2019
Q1 | $60K | Sell |
1,159
-449
| -28% | -$23.2K | ﹤0.01% | 1897 |
|
|
2018
Q4 | $59K | Hold |
1,608
| – | – | ﹤0.01% | 1940 |
|
|
2018
Q3 | $60K | Buy |
1,608
+617
| +62% | +$23K | ﹤0.01% | 2051 |
|
|
2018
Q2 | $39K | Sell |
991
-468
| -32% | -$18.4K | ﹤0.01% | 2266 |
|
|
2018
Q1 | $38K | Hold |
1,459
| – | – | ﹤0.01% | 2222 |
|
|
2017
Q4 | $39K | Buy |
+1,459
| New | +$39K | ﹤0.01% | 2194 |
|